3 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cortef®: new trials by email Literature Review of Cortef® trials Research Report on Cortef®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects Infacort®, Cortef® - Adrenal Insufficiency | Phase 1 | Completed | Neurocrine UK Limited | 51 | 2018-04-16 | 2026-09-14 |
| A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects Chronocort®, Cortef® - Adrenal Insufficiency | Phase 1 | Completed | Neurocrine UK Limited | 25 | 2018-02-19 | 2026-09-14 |
| NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma Prednisone, Vincristine, Daunorubicin - Lymphoblastic Lymphoma | Phase 2 | Completed | St. Jude Children's Research Hospital | 23 | 2012-05-25 | 2022-06-28 |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) EZN-3042, Cytarabine, Doxorubicin - Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Terminated | Therapeutic Advances in Childhood Leukemia Consortium | 6 | 2010-08-24 | 2024-02-01 |
Adrenal Insufficiency (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Neurocrine UK Limited (2) · St. Jude Children's Research Hospital (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
United Kingdom (2) · United States (2) · Australia (1)
A Koch (2) · Elizabeth Raetz, MD (1) · Hiroto Inaba, MD,PhD (1) · William Carroll, MD (1)